Similar articles

• Cyclophosphamide-induced transitional cell carcinoma of bladder in lupus nephritis.

  Chow SK, Looi LM, Loh CS, Yeap SS. Chow SK, et al. Intern Med J. 2002 Mar;32(3):114-6. Intern Med J. 2002. PMID: 11885838 No abstract available.
• Bladder cancer after cyclophosphamide therapy for lupus nephritis.

  Ortiz A, Gonzalez-Parra E, Alvarez-Costa G, Egido J. Ortiz A, et al. Nephron. 1992;60(3):378-9. doi: 10.1159/000186790. Nephron. 1992. PMID: 1565199 No abstract available.
• Cyclophosphamide-induced urinary bladder cancer: a case report.

  Shuin T, Kubota Y. Shuin T, et al. Jpn J Clin Oncol. 1983 Mar;13(1):75-80. Jpn J Clin Oncol. 1983. PMID: 6834654 No abstract available.
• [Carcinoma of the urinary bladder in a patient receiving cyclophosphamide for Wegener's granuloma: a case report].

  Shiba T, Noguchi S, Yao M, Takahashi T, Shuin T, Miura T, Kinoshita Y, Kubota Y, Hosaka M. Shiba T, et al. Hinyokika Kiyo. 1991 Apr;37(4):393-6. Hinyokika Kiyo. 1991. PMID: 1891999 Review. Japanese.
• [Bladder carcinoma in a case of multiple myeloma IgG (kappa) treated with cyclophosphamide: review of literature].

  Iwabuchi A, Hohjoh H, Fujieda H, Ohyashiki J, Ohyashiki K, Toyama K. Iwabuchi A, et al. Rinsho Ketsueki. 1988 Aug;29(8):1272-6. Rinsho Ketsueki. 1988. PMID: 3144618 Review. Japanese. No abstract available.